Individualized perampanel response and efficacy in patients with refractory epilepsy: the need for ATP-binding cassette B1 genotyping and therapeutic drug monitoring to work in tandem
- 29 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 36 (6) , 276-289
Abstract
Objective: This study analyzed the correlation and differences between the gene polymorphisms of ATP-binding cassette B1 ( ABCB1 ), which encode the efflux drug transporter P-glycoprotein, and the efficacy and plasma concentration of perampanel (PER) in patients with refractory epilepsy. Methods: Plasma samples were collected from 115 patients with epilepsy who received PER treatment for at least 21 days. The ABCB1 genotypes were detected using first-generation Sanger sequencing, and the PER plasma concentration was measured using ultra-high performance liquid chromatography-mass spectrometry. Results: The overall efficacy of PER in treating patients with refractory epilepsy was observed in 64.3% of patients. The ABCB1 rs2032582 gene polymorphisms were significantly associated with the therapeutic efficacy of PER in refractory epilepsy. When compared with patients with the wild-type homozygous genotype, the plasma concentrations of PER were significantly higher for patients with the P-glycoprotein-encoding ABCB1 rs2032582 and ABCB1 rs1045642 mutant genotypes ( P < 0.05). When the plasma concentration of PER exceeded 305 ng/ml, patients more effectively responded to PER treatment (area under the curve: 0.614, P < 0.05). Conclusion: ABCB1 gene polymorphisms are important predictors of effective with PER treatment and serve as factors that affect the achievement of therapeutic plasma concentrations of PER, and they have contrasting effects.Keywords
Funding Information
- 2024 Pharmaceutical Science and Technology Research Project of Chinese Medicine Education Association (2024KTM032)
- 2025 Special Research Project on High-Quality Development of Hospitals and Pharmaceutical Innovation of Chinese Medicine Education Assciation (2025-PJZXKT-10)
- Youth Talent Support Project of Tianshan Talents Training Program of Xinjiang Uygur Autonomous Region (2024TSYCQNTJ0046)
This publication has 40 references indexed in Scilit:
- Effectiveness and Safety of Perampanel in Refractory Focal Epilepsy: Real‐World Evidence From a Chinese CohortBrain and Behavior, 2025
- Effectiveness and safety of Perampanel in refractory status epilepticus: a case seriesNeurological Sciences, 2024
- Perampanel as an Add-On Therapy in Patients with Refractory Status Epilepticus and Postanoxic Encephalopathy: A Real-Life Single-Center Retrospective Cohort StudyNeurocritical Care, 2024
- Development and application of a novel LC–MS/MS method for human plasma concentration monitoring of perampanel in pediatric epilepsy patientsBiomedical Chromatography, 2022
- The Structure and Mechanism of Drug Transporters2021
- miR-23a-3p is involved in drug resistance by directly targeting the influx drug transporter organic anion-transporting polypeptide 2Child's Nervous System, 2021
- Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)Epilepsia Open, 2020
- Overview of Transporters in Pharmacokinetics and Drug DiscoveryCurrent Protocols in Pharmacology, 2018
- Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1Journal of Pharmacokinetics and Pharmacodynamics, 2017
- Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: An analysis in a western Chinese pediatric populationBrain Research, 2011